FY2026 EPS Estimates for Avanos Medical Lowered by Analyst

Avanos Medical, Inc. (NYSE:AVNS) – Stock analysts at Zacks Research dropped their FY2026 earnings per share (EPS) estimates for Avanos Medical in a research report issued to clients and investors on Tuesday, December 3rd. Zacks Research analyst R. Department now forecasts that the company will earn $2.00 per share for the year, down from their prior forecast of $2.01. The consensus estimate for Avanos Medical’s current full-year earnings is $1.32 per share.

Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Price Performance

Shares of Avanos Medical stock opened at $19.10 on Thursday. The company has a market cap of $877.84 million, a PE ratio of 56.18 and a beta of 0.95. The business has a 50 day moving average of $20.96 and a 200 day moving average of $21.51. Avanos Medical has a 52 week low of $17.39 and a 52 week high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Institutional Investors Weigh In On Avanos Medical

A number of institutional investors have recently modified their holdings of the stock. The Manufacturers Life Insurance Company grew its stake in shares of Avanos Medical by 3.6% in the second quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock worth $341,000 after acquiring an additional 590 shares during the last quarter. KBC Group NV grew its stake in shares of Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after acquiring an additional 1,095 shares during the last quarter. New York State Teachers Retirement System boosted its position in shares of Avanos Medical by 2.0% during the third quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock valued at $1,737,000 after buying an additional 1,388 shares during the last quarter. Quarry LP purchased a new stake in shares of Avanos Medical during the third quarter valued at $42,000. Finally, Foundry Partners LLC boosted its position in shares of Avanos Medical by 1.1% during the third quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock valued at $3,918,000 after buying an additional 1,800 shares during the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.